A study of clinico‐pathological parameters and O6 – methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma
Abstract:Gliosarcoma is a rare variant of glioblastoma multiforme (GBM) with similar clinical presentation and prognosis but a distinct genetic profile. The clinicopathological features of 22 cases of gliosarcoma were analyzed with respect to age, sex, KPS score, operative diagnosis, extent of resection and histopathological subtype (predominantly sarcomatous [PS], predominantly gliomatous [PG] or mixed). Twelve cases were PS, six were PG and four were mixed. The histological subtype did not correlate with the operativ… Show more
“…Tumors appearing close to bones with a wellcircumscribed margin were grouped as meningioma like and the remainder as GBM like, with a favourable outcome in the former group [7]. In the present series, two patients had meningioma-like feature and rest were GBM like.…”
Section: Discussionmentioning
confidence: 46%
“…The authors reported superior survival in the PSGS. In a cohort of PGS, Singh et al [7] reported superior survival in PSGS as compared to PGGS (18.5 vs. 8.5 months), though not statistically significant. In the present cohort, two patients each had PSGS and PGGS and one had mixed type.…”
Section: Discussionmentioning
confidence: 92%
“…We earlier reported the results of this regimen in the pediatric GBM patients [6]. Recently, Singh et al [7] reported improved survival of PGS patients treated with adjuvant radiotherapy followed by concurrent and maintenance temozolomide. Based on these results, this regimen appears feasible and is also associated with improved outcome in pPGS patients.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, methylation of the O6-methylguanine DNA methyltransferase (MGMT) has surfaced as the most important prognostic and predictive factor for GBM [7][8][9]. Therefore, investigators have looked into the MGMT methylation [7] reported 31 % MGMT methylation, but failed to correlate this with survival.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, investigators have looked into the MGMT methylation [7] reported 31 % MGMT methylation, but failed to correlate this with survival. Small sample size could have possibly masked the difference.…”
“…Tumors appearing close to bones with a wellcircumscribed margin were grouped as meningioma like and the remainder as GBM like, with a favourable outcome in the former group [7]. In the present series, two patients had meningioma-like feature and rest were GBM like.…”
Section: Discussionmentioning
confidence: 46%
“…The authors reported superior survival in the PSGS. In a cohort of PGS, Singh et al [7] reported superior survival in PSGS as compared to PGGS (18.5 vs. 8.5 months), though not statistically significant. In the present cohort, two patients each had PSGS and PGGS and one had mixed type.…”
Section: Discussionmentioning
confidence: 92%
“…We earlier reported the results of this regimen in the pediatric GBM patients [6]. Recently, Singh et al [7] reported improved survival of PGS patients treated with adjuvant radiotherapy followed by concurrent and maintenance temozolomide. Based on these results, this regimen appears feasible and is also associated with improved outcome in pPGS patients.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, methylation of the O6-methylguanine DNA methyltransferase (MGMT) has surfaced as the most important prognostic and predictive factor for GBM [7][8][9]. Therefore, investigators have looked into the MGMT methylation [7] reported 31 % MGMT methylation, but failed to correlate this with survival.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, investigators have looked into the MGMT methylation [7] reported 31 % MGMT methylation, but failed to correlate this with survival. Small sample size could have possibly masked the difference.…”
Prognostic value of test(s) for O 6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.